Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

UK Says Sovaldi Is Worth It. We Should Listen.
Forbes
Mon, 08/18/14 - 09:20 am
Tags:
UK, Sovaldi, hepatitis C, Gilead Sciences
Gilead says wins favorable ruling on hep C drug
Yahoo/Reuters
Fri, 08/15/14 - 11:42 am
Tags:
hepatitis C, Gilead Sciences, Roche, Sovaldi
UK Recommends Covering Sovaldi Hepatitis C Pill
WSJ Pharmalot
Fri, 08/15/14 - 05:19 am
Tags:
UK, Sovaldi, hepatitis C, Gilead Sciences
How Gilead Sciences Became A Big Name In Biotech
Investopedia
Tue, 08/12/14 - 08:31 am
Tags:
Gilead Sciences
Gilead bags a portfolio of HIV-neutralizing antibodies
Fierce Biotech
Wed, 07/30/14 - 06:37 pm
Tags:
Gilead Sciences, antibodies, HIV
Despite outcry over cost, breakthrough drug becomes treatment of choice for hepatitis C
Yahoo/AP
Tue, 07/29/14 - 09:35 am
Tags:
hepatitis C, Sovaldi, Gilead Sciences
5 Huge Biotech Catalysts Right Around the Corner for Top Stocks
24/7 Wall St
Mon, 07/28/14 - 12:26 pm
Tags:
Arrowhead Research, Gilead Sciences, Intercept Pharmaceuticals, Amgen, Vertex Pharmaceuticals, RNAi, Kyprolis, VX-661, Sovaldi, Kalydeco
Politicizing Gilead's Research And Development Costs For Sovaldi Is A Reckless And Dangerous Misadventure
Forbes
Sat, 07/26/14 - 09:56 am
Tags:
Sovaldi, Gilead Sciences, hepatitis, hepatitis C
Can Gilead break into cancer? With Zydelig approval, it gets its chance
Fierce Pharma
Fri, 07/25/14 - 09:16 am
Tags:
Gilead Sciences, Zydelig, PI3k inhibitor, Roche
Biotech Giant Blows Away Expectations After Selling $3.5 Billion Of Its 'Wonder Drug'
Yahoo/Business Insider
Thu, 07/24/14 - 08:35 am
Tags:
Gilead Sciences, Sovaldi, earnings
Gilead Sciences Beats Earnings Forecasts, Sovaldi Sales Strong, Shares Slump
Barron's
Wed, 07/23/14 - 06:09 pm
Tags:
Gilead Sciences, earnings, Sovaldi
FDA approves Gilead Sciences' Zydelig for 3 forms of blood cancer
Yahoo/AP
Wed, 07/23/14 - 04:33 pm
Tags:
FDA, Zydelig, Gilead Sciences, chronic lymphocytic leukemia, follicular lymphoma, small lymphocytic lymphoma
Gilead Sciences: Sovaldi’s a Blockbuster, the Question is How Big
Barron's
Mon, 07/21/14 - 11:01 am
Tags:
Gilead Sciences, Sovaldi, hepatitis C
Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers
WSJ Online
Mon, 07/21/14 - 10:35 am
Tags:
patents, hepatitis C, Gilead Sciences, Merck, AbbVie, Roche
CVS officials say Sovaldi pricing in line with history, but unsustainable
Marketwatch
Mon, 07/21/14 - 10:15 am
Tags:
CVS, Sovaldi, Gilead Sciences, hepatitis C
Top Biotech Earnings Previews for the Week Ahead
24/7 Wall St
Mon, 07/21/14 - 09:20 am
Tags:
earnings, Cubist Pharma, Gilead Sciences, Biogen Idec, Celgene, Illumina, Alexion
Gilead Drug Combination Cures Hepatitis C in HIV Patients
Yahoo/Bloomberg
Mon, 07/21/14 - 09:13 am
Tags:
Gilead Sciences, HIV, hepatitis C, Sovaldi, Ribavirin
Gilead: 50% Upside From Here
Seeking Alpha
Sat, 07/19/14 - 08:51 am
Tags:
Gilead Sciences
Will Gilead’s Hepatitis C Drug Bust State Budgets?
WSJ Online
Thu, 07/17/14 - 09:51 am
Tags:
Gilead Sciences, Sovaldi, hepatitis C
Gilead Stock Earnings: What to Watch
Motley Fool
Thu, 07/17/14 - 09:17 am
Tags:
Gilead Sciences, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.